Amazon’s Top Health Executive Departs, Amwell Co-Founder to Take Helm

Amazon’s top healthcare executive, Neil Lindsay, is stepping down, a move signaling a strategic shift for the e-commerce giant’s ambitious foray into the complex and lucrative healthcare sector. He will be succeeded by Dr. Roy Schoenberg, a prominent figure in telemedicine and co-founder of Amwell, a company recognized for its virtual care solutions.

Lindsay, who has been instrumental in shaping Amazon Health Services (AHS) since 2021, will transition to an advisory role until year-end. His tenure saw the integration and expansion of key AHS initiatives, including the Amazon Pharmacy online prescription service and the acquisition of the primary care provider One Medical. Prior to leading AHS, Lindsay held significant leadership positions within Amazon, including overseeing the Prime subscription service and global marketing for consumer devices, underscoring his broad operational expertise.

The appointment of Dr. Schoenberg, slated to take effect July 1, brings a wealth of experience to Amazon’s healthcare division. Doug Herrington, Amazon’s worldwide retail chief, highlighted Schoenberg’s “rare combination of clinical expertise, technology vision, and experience building healthcare businesses at scale” in a company memo. This move suggests a renewed focus on leveraging technological innovation and deep healthcare sector understanding to drive Amazon’s future healthcare strategy.

Amazon’s pursuit of a significant share in the multi-trillion dollar U.S. healthcare market has been a multi-year endeavor, marked by strategic acquisitions and the development of innovative services. The company’s initial major push into the sector was the $750 million acquisition of online pharmacy PillPack in 2018, which laid the groundwork for Amazon Pharmacy. This was followed by the landmark $3.9 billion acquisition of One Medical in 2023, providing Amazon with a substantial network of primary care clinics and a dedicated member base, significantly expanding its physical healthcare footprint.

While Amazon has explored various healthcare avenues, including a now-shuttered telehealth service and the Amazon Halo wearable device, its strategic vision continues to evolve. The recent launch of an artificial intelligence-powered health tool capable of analyzing medical records, scheduling appointments, and providing health-related information underscores Amazon’s commitment to integrating advanced technology into its healthcare offerings. This AI initiative represents a crucial step in harnessing data and machine learning to enhance patient care and operational efficiency.

Lindsay’s departure and Schoenberg’s arrival occur amidst a period of significant executive transitions within Amazon’s healthcare unit. These changes, including the departure of One Medical’s CEO and Amazon’s chief medical officer, suggest an ongoing recalibration of leadership to navigate the dynamic healthcare landscape. The broader trend of healthcare executives moving between major tech companies and established healthcare providers highlights the increasing convergence of technology and medicine.

Lindsay expressed his belief that the time is opportune for a leadership change, stating in his memo, “Now is the right time to step back and pass the baton to a leader who knows how to navigate the next phase of this journey better than I.” His decision to remain as an advisor and continue offering counsel to healthcare technology companies suggests his continued engagement with the sector’s innovation ecosystem. Dr. Schoenberg’s extensive background in building and scaling virtual care platforms positions him to steer Amazon’s healthcare initiatives through its next growth phase, focusing on integrated care models and leveraging digital health solutions.